Penta Investments group announced Thursday the acquisition of pharmacy network Mediq Apteka in Poland for more than $93 million in a deal launching Penta to the number-two spot in Poland’s pharmaceutical sector. While the buyout was completed last Wednesday night, antitrust regulators in the nation have yet to clear the transaction. According to reports, Penta currently controls about 70 pharmacies through the Dr. Max network; this latest buyout will add 300 new pharmacies to that portfolio, which Penta said would be incorporated into the Dr. Max network.
Featured News
Former FTC Litigator Appointed General Counsel of American Antitrust Institute
Jan 20, 2026 by
CPI
FTC Moves to Appeal Meta Antitrust Ruling Over Instagram and WhatsApp Acquisitions
Jan 20, 2026 by
CPI
Deutsche Boerse Nears €5.3 Billion Deal for Allfunds
Jan 20, 2026 by
CPI
Irish Appliance Maker Probed Over Alleged Price-Fixing Practices
Jan 20, 2026 by
CPI
UK Regulator Accuses Meta of Allowing Illegal Gambling Ads
Jan 20, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi